San Antonio—Mutations found in a patient’s primary breast cancer and metastatic sites can be different from evolutionary mutations seen in metastatic samples after they are treated.
The finding that tumors evolve in the metastatic setting differently from the primary setting, reported at the 2016 San Antonio Breast Cancer Symposium, has many implications for the treatment of women with metastatic breast cancer, perhaps pointing to new therapeutic approaches to overcome or prevent